0001375151-20-000115.txt : 20200630
0001375151-20-000115.hdr.sgml : 20200630
20200629215320
ACCESSION NUMBER: 0001375151-20-000115
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200625
FILED AS OF DATE: 20200629
DATE AS OF CHANGE: 20200629
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Galer Bradley S.
CENTRAL INDEX KEY: 0001594565
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34962
FILM NUMBER: 201000199
MAIL ADDRESS:
STREET 1: C/O ZOGENIX, INC.
STREET 2: 12400 HIGH BLUFF DR., SUITE 650
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ZOGENIX, INC.
CENTRAL INDEX KEY: 0001375151
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 205300780
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 5959 HORTON STREET, SUITE 500
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
BUSINESS PHONE: (510) 550-8300
MAIL ADDRESS:
STREET 1: 5959 HORTON STREET, SUITE 500
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
FORMER COMPANY:
FORMER CONFORMED NAME: ZOGENIX INC
DATE OF NAME CHANGE: 20060911
4
1
wf-form4_159348195885012.xml
FORM 4
X0306
4
2020-06-25
0
0001375151
ZOGENIX, INC.
ZGNX
0001594565
Galer Bradley S.
C/O ZOGENIX, INC.
5959 HORTON STREET, SUITE 500
EMERYVILLE
CA
94608
0
1
0
0
EVP/Chief Medical Officer
Common Stock
2020-06-25
4
M
0
10000
0
A
20015
D
Common Stock
2020-06-25
4
F
0
2813
28.12
D
17202
D
Restricted Stock Units
2020-06-25
4
M
0
10000
0
D
Common Stock
10000.0
0
D
The Restricted Stock Units (RSUs) were granted on March 14, 2017, with 100% of the RSUs to vest upon approval of the Company's New Drug Application (NDA) by the U.S. Food and Drug Administration for Fintepla. The NDA was approved on June 25, 2020.
Represents shares withheld to satisfy tax withholding obligations in connection with the vesting of shares of RSUs described in footnote 1.
Each RSU represents a contingent right to receive one share of Zogenix common stock.
Not applicable.
/s/ Thomas Doyle, Attorney-in-fact for Bradley Galer
2020-06-29